Skip to content

Septerna, Inc. SEPN Earnings yield

Earnings yield at other companies

Amgen logo
AmgenAMGN
4.1%+0.6pp
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
-8.8%-22.8pp
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
-18%+0.2pp
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
-7.2%-2.9pp
Maze Therapeutics, Inc. Common Stock logo
Maze Therapeutics, Inc. Common StockMAZE
-8.3%
Fortrea Holdings Inc. logo
Fortrea Holdings Inc.FTRE
-50.7%-18.3pp

Other financials

Income statement

See full
Revenue$26.5M+12,011%
Operating income-$13.3M+48.7%
Net income-$8.6M+59.8%
EPS (diluted)-$0.19+61.2%

Balance sheet

See full
Cash & equivalents$71.6M-65.9%
Total debt$23.1M-7.7%
Total equity$378.5M+195%
Total assets$569.7M+31.3%

Cash flow

See full
Operating cash flow-$25.6M-9.8%
CapEx$832.0K+118%
Free cash flow-$26.5M-11.5%

Valuation

See full
Market cap$1.62B+319%

Profitability

See full
Operating margin-77.1%-38.4pp
Net margin-49.9%-24.9pp
FCF margin467.9%+243pp

Returns & leverage

See full
Return on equity-12.2%
Debt / equity0.1×
Current ratio4.7×-27.5×

Where this comes from

Calculated from Septerna, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Septerna, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Septerna, Inc.'s earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Septerna, Inc.'s earnings yield?
Septerna, Inc. (SEPN) reported earnings yield of -3.3% in Q1 2026.
How has Septerna, Inc.'s earnings yield changed year-over-year?
Septerna, Inc.'s earnings yield increased by 89.1% year-over-year, from -30.8% to -3.3%.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.